FilingReader Intelligence

Kangtai Bio revises convertible bond conversion price downward

March 31, 2025 at 12:46 PM UTCBy FilingReader AI

Shenzhen Kangtai Biological Products has announced a downward revision of the conversion price for its "Kangtai Convertible 2" bonds (SZSE:123119), a decision made and approved during a series of board and shareholder meetings held throughout February and March 2025. Effective March 27, 2025, the new conversion price has been set at CNY 15.82 per share, reduced from the previous CNY 19.81 per share. This decision, based on the company's Articles of Association, became necessary when the company's stock price fell below 85% of the current conversion price for at least 15 out of 30 consecutive trading days.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Shenzhen Kangtai Biological Products publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →